← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2017Last known activity
Apr 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT05977400CollaboratorPhase 3Apr 30, 2024
- NCT04071600CollaboratorPhase 1/Phase 2Nov 1, 2019
- NCT04071600Overall official - principal investigatorPhase 1/Phase 2Nov 1, 2019
- NCT03390530CollaboratorPhase 2Jan 1, 2019
- NCT03056378CollaboratorPhase 1Jul 1, 2017
Details
- Last known activity
- Apr 30, 2024